OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LVTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

LAVA Therapeutics (LVTX) Earnings Date & Reports

LAVA Therapeutics NV isa clinical stage immuno-oncology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LVTX is expected to report earnings to fall 21.87% to -25 cents per share on November 12

LAVA Therapeutics LVTX Stock Earnings Reports

Q3'25

Est.

$-0.25

Q2'25

Missed

by $0.02

Q1'25

Beat

by $0.19

Q4'24

Beat

by $0.16

Q3'24

Missed

by $0.13

The last earnings report on August 13 showed earnings per share of -31 cents, missing the estimate of -30 cents. With 32.06K shares outstanding, the current market capitalization sits at 41.30M.

View a ticker or compare two or three

Compare

LVTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LVTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LVTX showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Yalelaan 62

Phone

+31 850163100

Employees

Web

https://www.lavatherapeutics.com